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Background: Glycosylation is one of the most common post-translational modifications of eukaryotic proteins and
is known to undergo dynamic changes in a wide range of biological processes. To date, however, the glycan
expression profiles in endometriosis are largely unknown. The objective of the study was to identify the panel of
glycans that were aberrantly expressed in endometriosis, a hormone-dependent disease.
Methods: The glycan expression profiles in primary cultured human endometriotic cyst stromal cells (ECSCs) and
normal endometrial stromal cells (NESCs) were determined by lectin microarray analysis. Distribution of Wisteria
floribunda agglutinin (WFA)-binding glycans in ovarian endometriotic cysts and eutopic proliferative phase
endometrium were assessed by lectin histochemistry. The expressions of N-acetylgalactosaminyl transferases that
synthesize WFA-binding glycans were evaluated in ECSCs and NESCs.
Results: We found that the levels of WFA-binding glycans were decreased in ECSCs. Lectin histochemistry revealed
that WFA-binding glycans were decreased only in the stromal components of the ovarian endometriotic cysts, but
not in the epithelial components, compared to the eutopic proliferative phase endometrium. The expressions of
N-acetylgalactosaminyl transferases that synthesize WFA-binding glycans were downregulated in ECSCs.
Conclusions: Utilizing lectin microarray analysis and lectin histochemistry, we found that WFA-binding glycans were
decreased in endometriosis. The synthetic enzymes of WFA-binding glycans were significantly downregulated in
ECSCs. It is suggested that reduced expression of N-glycans with WFA-binding properties on ECSCs is a novel
characteristics of endometriosis.
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Endometriosis is characterized by dysmenorrhea, chronic
pelvic pain and/or subfertility, all of which can significantly
impair the quality of life of young women, who comprise
the population most likely to suffer from this estrogen-
dependent disease [1]. Although endometriotic tissues and
normal proliferative endometrium are histologically similar,
several molecular differences between normal and endo-
metriotic tissues have been identified [2-5].
In the field of reproductive medicine and oncology, gly-
can profiling is attracting attention because it can provide* Correspondence: nasu@oita-u.ac.jp
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been estimated that 1% of the human genome is involved
in the production and modification of glycans [6]. Glycans
are produced in a non-template-driven manner in different
monosaccharides combine in a branched fashion and a
variety of orientations, producing isomeric and isobaric
glycans. Glycans have been shown to reflect cellular
conditions during development, differentiation, adhe-
sion, proliferation, aging, and activation, and, inflamma-
tion, infection, and tumorigenesis through specific
binding to their glycan ligands [7-11]. It has also been
estimated that as many as 70% of all human proteins are
glycosylated [12]. As one of the most common post-
translational modifications of eukaryotic proteins, gly-
cosylation undergoes dynamic changes in a wide rangeal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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in endometriosis have not been elucidated yet, which
encouraged us to carry out the present glycomic study.
Glycans are bound specifically by glycan-binding pro-
teins (GBPs), or lectins, which are diverse families of
ubiquitous proteins found in viruses, fungi, bacteria,
plants, and animals (including humans) [14,15]. The en-
dogenous functions of GBPs/lectins have not been well
established. Lectin microarrays, an emerging modern
technology, allow the ultrasensitive detection of multi-
plex lectin–glycan interactions. These arrays have been
used extensively in studies of pluripotent and somatic
stem cells and carcinogenesis [16-23].
The present study was designed to identify the panel
of glycans that were aberrantly expressed in primary cul-
tured human endometriotic cyst stromal cells (ECSCs)
in comparison with primary cultured human normal
endometrial stromal cells (NESCs). Lectin microarray
analysis revealed Wisteria floribunda agglutinin (WFA)-
binding glycans were significantly decreased in ECSCs
compared to NESCs. Thereafter, we focused on WFA
and evaluated the distribution of WFA-binding glycans
in the ovarian endometriotic cysts and to the eutopic
proliferative phase endometrium by lectin histochemis-
try. The expressions of N-acetylgalactosaminyl transfer-
ases that synthesize WFA-binding glycans were also
examined in ECSCs and NESCs. The present study may
provide a platform for the future studies on aberrant gly-
can expressions in endometriosis.Methods
Ethical approval
The present study was approved by the institutional re-
view board of the Faculty of Medicine, Oita University,
and signed informed consent was obtained from all pa-
tients (Reference No.: P-10-04; Date of approval: July 23,
2010). This study was conducted between September 1,
2013 and May 13, 2014.Tissue collection, ECSC and endometrial stromal cell
(NESC) isolation procedure
Endometriotic tissues were obtained from premeno-
pausal patients who had undergone a surgery for ovarian
endometriotic cysts (n = 35 in total, aged 26–37 years).
Normal endometrial tissues were obtained from premen-
opausal patients who had undergone hysterectomies for
subserosal leiomyoma and had no evidence of endomet-
riosis (n = 39 in total, aged 35–41 years). None of the pa-
tients had received any hormonal treatments for at least
2 years prior to the operation. All of the specimens were
diagnosed as being in the mid- to late-proliferative
phases, using a standard histological examination of the
endometrial tissues.Of these collected samples, sixteen endometriotic tissues
and twenty normal endometrial tissues were fixed in 7%
neutral buffered formaldehyde solution, embedded in par-
affin, and processed for lectin histochemical staining [24].
Whereas, other 19 ovarian endometriotic tissues and 19
normal eutopic endometrial tissues were processed for cell
isolation, as previously described [25,26]. Briefly, the tissues
were minced in Hank’s balanced salt solution and digested
with 0.5% collagenase (Gibco-BRL, Gaithersburg, MD,
USA) in Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco-BRL) at 37°C for 40 min. The dispersed cells were
filtered through a 70-μm nylon mesh to remove the un-
digested tissue pieces. The filtrated fraction was further
separated from epithelial cell clumps by differential sedi-
mentation at unit gravity as follows. The cells were resus-
pended in 2 ml of culture medium and layered slowly over
10 ml of the medium in a centrifuge tube. Sealed tubes
were placed in an upright position at 37°C in 5% CO2 in
air for 30 min. After sedimentation, the top 8 ml of the
medium was collected. Finally, the medium containing
stromal cells was filtered through a 40-μm nylon mesh.
Final purification was achieved by allowing stromal
cells, which rapidly attached to plates, to adhere select-
ively to culture dishes for 30 min at 37°C, followed by
the removal of non-adhering epithelial cells. Isolated
ECSCs and NESCs were cultured in DMEM supple-
mented with 100 IU/ml of penicillin (Gibco-BRL),
50 mg/ml of streptomycin (Gibco-BRL) and 10% heat-
inactivated fetal bovine serum (FBS) (Gibco-BRL) at
37°C in 5% CO2 in air. ECSCs and NESCs in monolayer
cultures after the third passage were >99% pure as ana-
lysed by immunocytochemical staining with antibodies
against vimentin (V9; Dako, Copenhagen, Denmark),
CD10 (SS2/36; Dako), cytokeratin (Dako), factor VIII
(Dako) and leukocyte common antigen (2B11 t PD7/26,
Dako) and were used for the following experiments
[25,26]. The cells separately isolated from individual pa-
tients were used in each experiment.
Protein extraction for lectin microarray
Cultured ECSCs (n = 9) and NESCs (n = 11) were har-
vested by trypsinization. The cells were pelleted by
washing with phosphate-buffered saline (PBS) by centri-
fugation, then solubilized with 20 μl of PBS containing
0.5% Nonidet P40, and sonicated gently. The cell sus-
pensions were incubated on ice for 60 minutes and cen-
trifuged at 20,000 g for 5 min at 4°C. The obtained
supernatants were used as detergent-solubilized glyco-
protein extract.
Lectin microarray analysis
Lectin microarray analysis was performed according to
the manufacturer’s instruction. Briefly, each 20 μl aliquot
of the above glycoprotein solutions was incubated with
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Tokyo, Japan) for 60 minutes at room temperature in
the dark. The obtained Cy3-labeled glycoprotein was sub-
jected to the lectin chip (LecChipTM; GP Biosciences,
Yokohama, Japan) that contain 45 lectins for human cells.
One hundred microliters of Cy3-labeled glycoprotein
solution in probing buffer (Tris-buffered saline containing
0.05% Triton X-100) were applied to each well with
immobilized lectins, at a concentration of 125 ng/ml. In-
cubation was performed at 4°C for about 15 hours until
the binding reached equilibrium. After the incubation,
we acquired a fluorescence image of the array using
an evanescent-field fluorescence scanner, GlycoStation™
Reader 1200, SC-Profiler (GP BioScience). We calculated
the net intensity value for each spot by subtracting a back-
ground value from signal intensity and averaged the signal
net intensity values of three spots. To calculate the fold
change of each lectin-binding glycans in ECSCs (n = 9)
relative to NESCs (n = 11), the data for a given lectin were
normalized to the median of that lectin in the eleven
NESCs. Among 45 lectins, differentially expressed lectins
were statistically extracted by a fold change of >2.0 com-
bined with two-sided Mann–Whitney U test, with the
Benjamini-Hochberg adjustment for false discovery rate
(FDR) (p < 0.05).
Lectin histochemistry
Lectin histochemical staining using streptavidin-biotin-
peroxidase method was performed with biotinylated
WFA (B-1355, Vector Laboratories, Peterborough, UK).
Dewaxed and hydrated sections of ovarian endometriotic
cyst (n = 16) and proliferative phase eutopic endomet-
rium (n = 20) were immersed in 10 mM citric acid
(pH 6.0) and autoclaved at 120°C for 10 min. Antigen
activated sections were immersed in 0.3% hydrogen per-
oxide in methanol at room temperature for 10 min to
block endogenous peroxidase activity, rinsed, micro-
waved in ethylenediaminetetraacetic acid buffer (1 mM,
pH 8.0) for 10 min and equilibrated in PBS. Sections
were blocked with 1% bovine serum albumin at room
temperature for 10 min, before overnight incubation
in 10 μg/ml biotinylated WFA at room temperature
for 150 min. The sections were rinsed in PBS before in-
cubation with Streptavidin-peroxidase reagent (424021,
Histofine simple stain SAB-PO (M) kit, Nichirei Co.,
Tokyo, Japan) at room temperature for 5 min. Sub-
sequently, the sections were rinsed in distilled water be-
fore 60 sec-incubation with 3,3’-diaminobenzidine tetra
hydrochloride (Histofine DAB substrate kit, Nichirei
Co.). Sections were washed in distilled water, coun-
terstained with hematoxylin, dehydrated, cleared and
mounted. Histochemical staining score was used to as-
sess the staining intensity with light microscopy (Zeiss
Axiophot; Carl Zeiss, Oberkochen, Germany).Total RNA isolation and quantitative reverse
transcription-polymerase chain reaction (RT-PCR) for
N-acetylgalactosaminyl transferases
WFA binds with high affinity to glycans containing N-
acetyl-D-galactosamine (GalNAc), namely GalNAcb1-
3Gal, GalNAcb1-4Gal, and GalNAcb1-4GlcNAc [27].
Whereas, the cognate glycosyltransferases of WFA in-
clude β1,3-N-acetylgalactosaminyl transferase (B3GALNT)
1, B3GALNT2, β1,4-N-acetylgalactosaminyltransferase (B4
GALNT) 1, B4GALNT2, B4GALNT3, and B4GALNT4
[28]. Therefore, we next evaluated the expression of these
N-acetylgalactosaminyl transferases in ECSCs and NESCs.
Total RNA from cultured ECSCs (n = 7) and NESCs
(n = 5) was extracted with a RNeasy Mini kit (Qiagen,
Valencia, CA, USA). The quality of the extracted RNA
was confirmed by measuring the absorbance at 230 nm,
260 nm, and 280 nm using a spectrophotometer (Nano-
Drop 2000, Thermo Scientific, Wilmington, DE, USA),
and subjected to RT-PCR as described previously [24].
Quantitative RT-PCR was carried out in with a Light-
Cycler 480 (Roche Diagnostics, Penzberg, Germany)
using the TaqMan Universal PCR Master Mix II No
AmpErase UNG (Applied Biosystems) with B3GALNT1-
specific (Assay ID: Hs00364202_s1, Applied Biosystems,
Carlsbad, CA, USA), B3GALNT2-specific (Assay ID: Hs00
380823_m1, Applied Biosystems), B4GALNT1-specific
(Assay ID: Hs00155195_m1, Applied Biosystems), B4G
ALNT2-specific (Assay ID: Hs00396440_m1, Applied
Biosystems), B4GALNT3-specific (Assay ID: Hs0041
9636_m1, Applied Biosystems), B4GALNT4-specific
(Assay ID: Hs00331790_m1, Applied Biosystems) or glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH)-specific
(Assay ID: Hs02758991_g1, Applied Biosystems) primers
[24]. Data from the RT-PCR experiments are presented as
the percentage of each N-acetylgalactosaminyl transferase/
GAPDH of ECSCs to those of NESCs.
Western blot analysis
The protein levels of N-acetylgalactosaminyl transferases
in ECSCs (n = 3) and NESCs (n = 3) were investigated by
Western blot analysis [24]. Antibodies against B3GALNT1
(ab98873, Abcam, Tokyo, Japan), B3GALNT2 (ab156785,
Abcam), B4GALNT1 (ab55065, Abcam), B4GALNT2
(ab176856, Abcam), B4GALNT3 (ab82800, Abcam),
B4GALNT4 (sc-166982, Santa Cruz Biotechnology, CA,
USA) and GAPDH (Ambion, Austin, TX, USA) were used
as primary antibodies. The relative expression of each N-
acetylgalactosaminyl transferase protein in ECSCs and
NESCs was analyzed using Image Lab™ software (Bio-Rad
Laboratories, Hercules, CA, USA).
Statistical analysis
Data were calculated as percentages to the corresponding
controls, presented as means ± SD, and were appropriately
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dent’s t test, or Bonferroni test with Sigmaplot 11.2 (Systat
Software, San Jose, CA, USA). Values of p < 0.05 were con-
sidered statistically significant.
Results
Identification of glycans differentially expressed in ECSCs
and NESCs
We used a lectin microarray platform covering a total of
45 human lectins to determine the expression patterns of
glycans in ECSCs (n = 9) and NESCs (n = 11). Unsuper-
vised hierarchical cluster analysis of these 45 lectins
showed that the patterns of glycan expression in ECSCs
were similar to those in NESCs as a whole (Figure 1), sug-
gesting that diseased tissues in endometriosis retain the
characteristics of their origin, namely the eutopic endomet-
rium, concerning lectin-binding glycan expression profiles.
To identify the group of glycans that are differentially
expressed between ECSCs and NESCs, we chose lectin-
binding glycans with a fold change of >2.0 from 45 lectins.
As shown in Table 1, we found that only WFA-binding
glycans were significantly downregulated in ECSCs by
using the two-sided Mann–Whitney U test and adjusted
FDR of <0.05. Whereas, none of the lectin-binding glycans
were found to be statistically upregulated in ECSCs com-
pared to NESCs.
Distribution of WFA-binding glycans in ovarian endometriotic
cysts and normal eutopic endometrium
We focused on WFA for the following experiments. Both
the glandular epithelial cells and the stromal componentFigure 1 Unsupervised hierarchical clustering of ECSCs and NESCs. EC
expression profiles with 45 lectin probes that meet the filtering criteria. Un
that the patterns of glycan expression in ECSCs were similar to those in NE
retain the characteristics of their origin, namely the eutopic endometrium,of ovarian endometriotic cysts as well as the normal prolif-
erative phase endometrium were positive for WFA-
binding glycans with strong to weak intensity (Figure 2
and Table 2). Significantly decreased staining for WFA-
binding glycans was observed in endometriotic stromal
component in comparison with eutopic endometrium.
Whereas, similar staining patterns were observed in the
epithelial component in these tissues.
Messenger RNA (mRNA) expression of N-acetylgalactosaminyl
transferases in ECSCs and NESCs
The mRNA expressions of B3GALNT1, B3GALNT2,
B4GALNT1, B4GALNT2, B4GALNT3, and B4GALNT4
in ECSCs and NESCs were evaluated by quantitative RT-
PCR. As shown in Figure 3, the mRNA expressions of
B3GALNT2, B4GALNT1, B4GALNT2, B4GALNT3,
and B4GALNT4 in ECSCs were significantly lower than
those in NESCs. Although there was no significance, the
mRNA expression of B3GALNT1 tends to decrease in
ECSCs compared to NESCs.
Protein levels of N-acetylgalactosaminyl transferases in
ECSCs and NESCs
The protein expressions of B3GALNT1, B3GALNT2,
B4GALNT1, B4GALNT2, B4GALNT3, and B4GALNT4
in ECSCs and NESCs were evaluated by Western blot
analysis. As shown in Figure 4, the protein expressions
of B3GALNT1, B3GALNT2, B4GALNT2, and B4GALNT3
were detected in ECSCs and NESCs. The levels of these
four N-acetylgalactosaminyl transferases were significant
higher in NESCs compared to ECSCs. Whereas, the proteinSCs (n = 9) and NESCs (n = 11) were clustered according to the glycan
supervised hierarchical clustering analysis of these 45 lectins showed
SCs as a whole, suggesting that diseased tissues in endometriosis
concerning glycan expression profiles.
Table 1 The lectin signals between ECSCs (n = 9) and NESCs (n = 11) obtained from a lectin microarray analysis
Lectin ECSC signals NESC signals ECSC/NESC FDR-adjusted
(Mean ± SD) (Mean ± SD) Signal ratio p-value
GSL-II 2.9111 ± 2.685 12.773 ± 21.907 0.228 0.506
WFA 8.578 ± 4.499 23.691 ± 10.474 0.362 0.031
EEL 10.422 ± 7.788 24.227 ± 33.06 0.430 0.442
GSL_I_A4 14.5 ± 14.009 33.018 ± 51.382 0.439 0.459
GSL_I_B4 12.344 ± 12.107 27.973 ± 33.193 0.441 0.481
VVA 11.122 ± 7.198 24.918 ± 22.587 0.446 0.596
ECA 9.722 ± 5.908 19.2 ± 17.569 0.506 0.59
UEA_I 6.033 ± 5.96 11.909 ± 14.76 0.507 0.486
DBA 12.133 ± 8.693 23.536 ± 21.247 0.516 0.521
PTL_I 12.2 ± 12.806 22.136 ± 33.735 0.551 0.508
SBA 13.178 ± 10.764 23.7 ± 20.775 0.556 0.571
HHL 17 ± 9.687 30.473 ± 28.645 0.558 0.541
PWM 9.744 ± 5.585 17.182 ± 9.881 0.567 0.45
MAH 16.8 ± 5.232 28.836 ± 27.646 0.583 0.464
ABA 90.233 ± 22.797 143.064 ± 120.478 0.631 0.483
PNA 4.967 ± 4.438 7.791 ± 8.819 0.637 0.501
MPA 15.444 ± 4.319 22.818 ± 30.326 0.677 0.554
TxLC_I 17.422 ± 9.327 24.845 ± 19.056 0.701 0.492
ACG 64.922 ± 34.0556 92.445 ± 37.676 0.702 0.585
MAL_I 18.056 ± 12.372 24.864 ± 22.1 0.726 0.511
BPL 25.8 ± 7.434 34.618 ± 15.621 0.745 0.533
SNA 33.144 ± 13.886 44.355 ± 34.96 0.747 0.488
SSA 36.811 ± 15.962 48.909 ± 27.953 0.753 0.495
PHA(L) 12.533 ± 5.879 16.264 ± 6.687 0.771 0.453
RCA120 66.022 ± 16.372 82.918 ± 31.243 0.796 0.528
TJA-II 37.367 ± 15.26 45.945 ± 12.496 0.813 0.461
GNA 93.978 ± 23.352 109.018 ± 43.165 0.862 0.504
WGA 98.011 ± 25.708 112.455 ± 31.601 0.872 0.475
TJA-I 49.278 ± 24.915 55.745 ± 16.598 0.884 0.611
AAL 52.178 ± 18.876 58.445 ± 20.733 0.893 0.595
Calsepa 45.089 ± 15.359 49.445 ± 28.858 0.912 0.775
Jacalin 168.8 ± 35.876 172.218 ± 42.136 0.98 0.847
STL 679.567 ± 70.057 656.364 ± 168.174 1.0354 0.77
NPA 179.722 ± 54.043 172.7 ± 50.535 1.0407 0.787
PHA(E) 146.678 ± 36.955 139.018 ± 49.862 1.055 0.766
ACA 145.689 ± 51.242 136.455 ± 66.262 1.068 0.763
LTL 33.667 ± 13.814 31.255 ± 16.35 1.077 0.777
LEL 548 ± 50.485 508.155 ± 117.768 1.078 0.508
UDA 313.967 ± 37.292 285.464 ± 71.134 1.1 0.502
DSA 443.7 ± 77.582 396.864 ± 132.835 1.118 0.494
HPA 89.722 ± 26.453 73.982 ± 41.287 1.213 0.509
PSA 85.311 ± 14.361 66.655 ± 22.578 1.28 0.433
AOL 91.611 ± 17.239 70.855 ± 24.037 1.293 0.568
LCA 263.311 ± 42.57 198.2 ± 70.68 1.329 0.477
ConA 393.767 ± 112.746 294.991 ± 141.82 1.335 0.642
FDR, false discovery rate.
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Figure 2 Distribution of WFA-binding glycans in ovarian endometriotic cysts and normal proliferative phase endometrium. Both the
glandular epithelial cells and the stromal component of ovarian endometriotic tissues as well as the normal proliferative phase endometrium
were positive for WFA-binding glycans with strong to weak intensity depending on the samples (hematoxylin & eosin staining, original
magnification ×40). Staining intensity for WFA-binding glycans assessed by histochemical staining score is summarized in Table 2.
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NESCs were under the detection levels.
Discussion
The current study was conducted to identify the panel of
aberrantly expressed glycans in ECSCs in comparison with
those in NESCs. Utilizing the lectin microarray technique,
we found, for the first time, that WFA-binding glycans
were decreased in ECSCs. Lectin histochemistry revealedTable 2 WFA-staining scores in ovarian endometriotic cysts (n
samples (n = 20)
Epithelial component





Mean ± SD 2.3 ± 0.8 2.5 ± 0.
The WFA-staining intensity was evaluated separately for the epithelial component a
(moderate), and 3 (strong). Two gynecologists (K. K. and M. Y.) scored all samples in
*p < 0.05 vs. eutopic endometrium (Student’s t-test).that WFA-binding glycans were decreased only in the
stromal components of the ovarian endometriotic cysts,
but not in the epithelial components, compared to the
eutopic proliferative phase endometrium. Thereafter, we
focused on the synthetic enzymes of WFA-binding glycans
and designed further experiments. The mRNA levels of
B3GALNT2, B4GALNT1, B4GALNT2, B4GALNT3, and
B4GALNT4 were significantly downregulated in ECSCs,
whereas the protein levels of B3GALNT1, B3GALNT2,= 16) and proliferative-phase eutopic endometrium
Stromal component





8 1.6 ± 0.9* 2.3 ± 0.8
nd the stromal component and stratified as follows: 0 (negative), 1 (weak), 2
dependently, and discrepancies were resolved by simultaneous examination.
Figure 3 mRNA expression of N-acetylgalactosaminyl transferases in ECSCs and NESCs. The mRNA expressions of B3GALNT1, B3GALNT2,
B4GALNT1, B4GALNT2, B4GALNT3, and B4GALNT4 in ECSCs (n = 7) and NESCs (n = 5) were evaluated by quantitative RT-PCR. *p < 0.025 and
**p < 0.0001vs. NESCs (Student’s t test).
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ulated in ECSCs. The meanings of aberrant glycan expres-
sions in endometriosis are not elucidated from the present
study, however, it is speculated that aberrantly expressed
glycans in ECSCs may involve in the development of
disease-specific features of endometriosis. The present
findings may provide a platform for the future glycomic
studies in endometriosis.
A huge number of possible unique sequences can be
composed of glycans, from basic building units. Glycans
are thus excellent information-coding “tools”. Cummings
[29] estimated that up to 500,000 glycan-modified biomol-
ecules may form a cellular glycome, based on 7,000 unique
glycan sequences. Arnaud et al. [30] estimated that in
humans, 70% of proteins and (80% of membrane-bound
proteins) are glycosylated. Indeed, glycosylation is a very
common type of post-translational modification of pro-
teins, with important roles in a wide range of cellular
events. Cell development, differentiation, morphogenesis,
proliferation, adhesion, fertilization, embryogenesis, im-
munity, infection, and tumorigenesis have all been shown
to involve protein glycosylation [7-11,31-33].
Oncology researchers have studied aberrant glycosyla-
tion extensively. For example, the invasion and metastatic
potential of cancer cells were found to be strongly corre-
lated cell surface sialylation and the β1–6 branching of
N-glycans [33-36]. The heavily O-glycosylated tumor-
associated mucin known as sialylated mucin 1 [37] ex-
presses Tn (GalNAc) antigens and T (Galb1, 3GalNAc)
antigens that are linked to cellular adhesion and function-
ing of the immune system [38,39]. In addition, several
glycan-based biomarkers have been established, including
α-fetoprotein 1 [40], prostate-specific antigen [41], thecarcino-embryonic antigen family [42,43], and cancer anti-
gen 19–9 [44]. The complete array of glycans associated
with endometriosis has not been determined.
Lectins each have a unique specificity profile, and the
differing specificities for complex glycans make lectins a
valuable tool for identifying a particular type of glycan.
Together the lectins comprise a diverse group of
carbohydrate-binding proteins [10]. Lectin microarrays
are used to profile the many types of glycan structures
observed at the cell surface and in glycoconjugates [10].
Berkes et al. [45] evaluated the plasma N-glycan levels in
endometriosis patients by hydrophilic interaction high
performance liquid chromatography and found the signifi-
cant decrease of some of the glycan peaks. In the present
study, we used a recently developed lectin microarray that
consists of 45 lectins with different binding preferences
covering N- and O-linked glycans [23] and we found that
WFA-binding glycans were decreased in ECSCs.
The reactivity of WFA is well-documented in mammary
glands [46], cholangiocarcinoma [16,17], prostate cancer
[47], and the central nervous system [48]. WFA reactivity
was shown to be upregulated in prostate cancer [47] and
cholangiocarcinoma [17]. Matsuda et al. [17] demonstrated
that WFA reactivity was associated with MUC1 in cholan-
giocarcinoma. WFA specifically recognizes terminal α/β-N-
acetylgalactosamine residues on N-glycans [28,46,49].
The genes B3GALNT1, B3GALNT2, B4GALNT2, and
B4GALNT3 synthesize WFA-binding glycans [28], and we
found that their expressions were significantly downregu-
lated in ECSCs, a finding that is consistent with the
present lectin microarray and lectin histochemistry results.
In some tumors, glycosyltransferase expression levels were
shown to be up- or down-regulated [50-53]. We did not
Figure 4 Protein levels of N-acetylgalactosaminyl transferases in ECSCs and NESCs. (A) Results of Western blot analysis. (B) Relative protein
levels of N-acetylgalactosaminyl transferases in ECSCs (n=3) and NESCs (n=3). The levels of B3GALNT1, B3GALNT2, B4GALNT2, and B4GALNT3 were
significant higher in NESCs compared to ECSCs. Whereas, the protein expressions of B4GALNT1 and B4GALNT4 in ECSCs and NESCs were under
the detection levels. *p < 0.005 vs. NESCs (Student’s t test).
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http://www.rbej.com/content/12/1/100evaluate which glycoproteins were affected by these de-
creased N-acetylgalactosaminyl transferases in the present
study. Further detailed examinations of this matter are
needed to elucidate the importance of aberrant glycan
expression in the pathogenesis of endometriosis.
To our knowledge, hormonal regulation of glycan
expressions in the normal cyclic endometrium as well
as the diseased endometrium has not been elucidated
yet. Whereas, we did not evaluate the glycan profiles in
the eutopic endometrium of the endometriosis patients
in the present study. These are the limitations of the
present study and we would like to elucidate these points
in the future.
Conclusions
Utilizing lectin microarray analysis and lectin histochemis-
try, we found that WFA-binding glycans were decreased
in ECSCs. The synthetic enzymes of WFA-binding glycans
were significantly downregulated in ECSCs. It is suggested
that reduced expression of N-glycans with WFA-binding
properties on ECSCs is a novel characteristics of endo-
metriosis. Further studies on the repertoire of glycomics
may provide useful information on the pathogenesis of
endometriosis.
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